Orforglipron Capsules | 6mg | 60 Capsules
$179.99
Research-grade Orforglipron capsules. 6mg per capsule, 60 capsules per bottle. HPLC-MS tested, >98% purity. CAS# 2212020-52-3. Oral GLP-1 receptor agonist. For research use only.
In stock (can be backordered)
- Description
- FDA Disclosure & Intended Use
- Storage Instructions
- Reviews (0)
- Research Use Only (RUO) Policy
Description
Description
Oral GLP-1 Receptor Agonist · Research Grade · Metabolic Collection →
Orforglipron Research Capsules
Captide Labs Orforglipron capsules provide researchers with a precisely dosed, encapsulated format of one of the most significant small-molecule GLP-1 receptor agonists to emerge from contemporary metabolic drug research. Each capsule delivers 6mg of Orforglipron at greater than 98% purity, independently verified by HPLC-MS analysis and documented with a full Certificate of Analysis.
Orforglipron (CAS 2212020-52-3) is a non-peptidic, oral small-molecule GLP-1 receptor agonist developed by Eli Lilly. Unlike peptide-based GLP-1 agonists which require injection, Orforglipron is orally bioavailable — a property that has made it a subject of intense clinical and preclinical research interest in the fields of obesity, type 2 diabetes, and cardiometabolic disease.
|
Compound
Orforglipron
|
CAS Number
2212020-52-3
|
|
Molecular Formula
C₂₄H₂₂F₂N₆O₂
|
Purity
>98% (HPLC-MS Verified)
|
|
Format
Encapsulated Powder
|
Amount Per Capsule
6mg
|
|
Capsules Per Bottle
60
|
Testing Standard
ISO 17025 Accredited Lab
|
|
Other Ingredients
Gelatin (Vegan), Rice Flour, Silicon Dioxide
|
|
What is Orforglipron?
Orforglipron is a non-peptidic small molecule that acts as a full agonist at the glucagon-like peptide-1 (GLP-1) receptor. GLP-1 is an incretin hormone secreted by intestinal L-cells in response to food intake, playing central roles in glucose-dependent insulin secretion, glucagon suppression, gastric emptying, and appetite regulation via central nervous system pathways.
What distinguishes Orforglipron from earlier GLP-1 receptor agonists such as semaglutide and liraglutide is its small-molecule, non-peptidic structure — enabling oral bioavailability without the formulation complexity required for oral peptide delivery. It has advanced through Phase 3 clinical trials for type 2 diabetes and obesity, generating significant research interest in its receptor pharmacology, metabolic effects, and potential cardiovascular benefits.
Areas of active investigation
Frequently Asked Questions
For research use only. Not for human consumption, veterinary use, or food/agricultural applications. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any condition. All purchases are made with the understanding that this compound is strictly for in-vitro research and laboratory use.
FDA Disclosure & Intended Use
FDA Disclosure: The statements on this website and the products sold herein have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease. Products sold are for Research Use Only and are not for human or animal use.
Intended Purpose: Products sold on this site are intended solely for basic laboratory research, pharmaceutical research, or the development of new tests. They are not intended for diagnostic, therapeutic, or clinical use.
Storage Instructions
Handling and Storage Tips:
- Keep peptides cold and away from light once received.
- For short-term use (days to weeks), refrigeration at 4°C (39°F) is acceptable.
- Lyophilized peptides are typically stable at room temperature for several weeks, making it suitable for moderate-term storage.
- For long-term storage (months to years), it’s best to freeze peptides at -80°C (-112°F). Freezing optimally preserves peptide stability for extended periods.
Reviews (0)
Research Use Only (RUO) Policy
"RUO" is an abbreviation for Research Use Only. It is a designation used primarily by the FDA (Food and Drug Administration) for products, often in vitro diagnostic (IVD) components like reagents or instruments, that are in the laboratory research phase of development and are not intended for clinical diagnostic use.
READ MORE
Reviews
There are no reviews yet.